Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51). http://www.samhsa.gov/data/. Accessed May 29, 2018.
2.
GonzalvoJDdeGrootMRinkerJet al. Mental health in people with diabetes: a needs assessment for the diabetes educator. AADE in Practice. In press.
3.
Young-HymanDde GrootMHill-BriggsFet al. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39:2126-2140.
AndersonRJFreedlandKEClouseRELustmanPJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069-1078.
6.
McGillDEVolkeningLKPoberMDet al, Depressive symptoms at critical times in youth with Type 1 diabetes: following Type 1 diabetes diagnosis and insulin pump initiation. J Adolesc Health. 2018;62(2):219-225.
7.
HoodKKHuestisSMaherAet al, Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diabetes Care. 2006;29(6):1389-1391.
8.
MatlockKAYayah JonesNHCorathersSDKichlerJ. Clinical and psychosocial factors associated with suicidal ideation in adolescents with type 1 diabetes. J Adolesc Health. 2017;61(4):471-477.
9.
Van BurenDJWilfleyDEMarcusMDet al. Depressive symptoms and glycemic control in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Res Clin Pract. 2018;135:85-87.
10.
SilversteinJChengPRuedyKJet al. Depressive symptoms in youth with type 1 or type 2 diabetes: results of the pediatrics diabetes consortium screening assessment of depressing in diabetes study. Diabetes Care. 2015;38(12):2341-2343.
11.
de GrootMCrickKALongMet al. Lifetime duration of depressive disorders in patients with type 2 diabetes. Diabetes Care. 2016;39(12): 2174-2181.
12.
KesslerRCBerglundPDemlerOet al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
13.
LustmanPJGriffithLSClouseRE. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care. 1988;11:605-612.
14.
GoldenSHLazoMCarnethonMet al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751-2759.
15.
MezukBEatonWWAlbrechtSGoldenSH. Depression and type 2 diabetes over the lifespan:a meta-analysis. Diabetes Care. 2008;31:2383-2390.
16.
LustmanPJAndersonRJFreedlandKEet al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23;934-942.
17.
de GrootMAndersonRFreedlandKEet al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619-630.
18.
CiechanowskiPSKatonWJRussoJE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278-3285.
19.
Von KorffMKatonWLinEHet al. Potentially modifiable factors associated with disability among people with diabetes. Psychosom Med. 2005;67:233-240.
20.
LinEHHeckbertSRRutterCMet al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med. 2009;7:414-421.
21.
KatonWJRutterCSimonGet al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28:2668-2672.
22.
de GrootMDoyleTAverytJ. Program ACTIVE: cognitive behavioral therapy to treat depression in adults with type 2 diabetes in rural Appalachia. J Cogn Psychother. 2017;33(1):158-170.
23.
PietteJDRichardsonCHimleJet al. A randomized trial of telephonic counseling plus walking for depressed diabetes patients. Med Care. 2011 ;49(7);641-648.
24.
LustmanPJGriffithLS. Cognitive behavior therapy for depression in type 2 diabetes mellitus. Ann Intern Med. 7998;129(8): 613-621.
25.
KatonWJLinEHVon KorffMet al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363: 2611-2620.
26.
GrigsbyABAndersonRJFreedlandKEet al. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res. 2002;53:1053-1060.
27.
HermannsNKulzerBKrichbaumMet al. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med. 2005;22:293-300.
28.
RechenbergKWhittemoreRGreyM. Anxiety in youth with type 1 diabetes. J Pediatr Nurs. 2017;32:64-71.
29.
SmithKJBelandMClydeMet al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74:89-99.
30.
FisherLSkaffMMMullanJTet al. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med. 2008;25:1096-1101.
31.
AtlantisEVogelzangsNCashmanKet al. Common mental disorders associated with 2-year diabetes incidence: the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2012;142:S30-S35.
32.
HusarewyczMNEl-GabalawyRLogsettySet al. The association between number and type of traumatic life experiences and physical conditions in a nationally representative sample. Gen Hosp Psychiatry. 2014;36:26-32.
33.
SnoekFJPouwerFWelchGWet al. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: Cross-cultural validity of the problem areas in diabetes scale. Diabetes Care. 2000;23:1305-1309.
34.
ShepardJAVajdaKNyerMet al. Understanding the construct of fear of hypoglycemia in pediatric type 1 diabetes. J Pediatr Psychol. 2014;39:1115-1125.
35.
BahrmannAAbelAZeyfangAet al. Psychological insulin resistance in geriatric patients with diabetes mellitus. Patient Educ Couns. 2014;94:417-422.
36.
EllKKatonWXieBet al. Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diabetes Care. 2010;33:706-713.
37.
van SonJNyklicekIPopVet al. The effects of a mindfulness-based intervention on emotional distress, quality of life, and HbA(1c) in outpatients with diabetes (DiaMind): a randomized controlled trial. Diabetes Care. 2013;36(4):823-830.
YoungVEiserCJohnsonBet al. Eating problems in adolescents with type 1 diabetes: a systematic review with metaanalysis. DiabetMed. 2013;30:189-198.
40.
RodinGOlmstedMPRydallACet al. Eating disorders in young women with type 1 diabetes mellitus. J Psychosom Res. 2002; 53:943-949.
41.
Young-HymanD. Eating disorders and disordered eating behavior. In: Psychosocial Care, oung-HymanDPeyrotM, eds. Washington, DC: American Diabetes Association; 2012:17-32.
42.
Goebel-FabbriAE. Disturbed eating behaviors and eating disorders in type 1 diabetes: Clinical significance and treatment recommendations. Curr Diab Rep. 2009;9:133-139.
FisherLHesslerDMPolonskyWHet al. When is diabetes distress clinically meaningful? Establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012;35:259-264.
45.
AikensJE. Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care. 2012;35(12): 2472-2478.
46.
HaggerVHendrieckxCSturtJ.et al. Diabetes distress among adolescents with type 1 diabetes: a systematic review. Curr Diab Rep. 2016;16:9.
47.
HesslerDFisherLPolonskyWJohnsonN. Understanding the areas and correlates of diabetes-related distress in parents of teens with type 1 diabetes. J Pediatr Psychol.2016;41(7):750-758.
48.
BiesselsGJDearyIJRyanCM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008;7(2):184-190.
49.
GudalaKBansalDSchifanoFBhansaliA. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4:640-650.
50.
LuchsingerJAReitzCPatelBet al. Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007;64:570-575.
51.
LuchsingerJATangMXSternYet al. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154:635-641.
52.
RyanCM. Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr Diabetes2006;7:289-297.
53.
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007;356:1842-1852.
54.
LuchsingerJA. Diabetes, related conditions, and dementia. J Neurol Sci. 2010;299(1-2):35-38.
55.
FergusonSCBlaneAWardlawJet al. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care. 2005;28:1431-1437.
56.
DahlquistGKallenB. School performance in children with type 1 diabetes—a population-based register study. Diabetologia. 2007;50:957-964.
57.
PaltaPSchneiderALBiesselsGJet al. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc. 2014;20(3): 278-291.
58.
ChristmanALVannorsdallTDPearlsonGDHill-BriggsFSchretlenDJ. Cranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample. Arch Clin Neuropsychol. 201025(1):49-59.
59.
Institute of Medicine. Health care response to cognitive aging. In: BlazerDGYaffeKLivermanCT, eds. Cognitive Aging: Progress in Understanding and Opportunities for Action. Washington, DC: National Academies Press; 2015:209-226. https://www.nap.edu/read/21693/chapter/9. Accessed March 1, 2018.
60.
American Diabetes Association. Older adults: standards of medical care in diabetes 2018. Diabetes Care. 2018;41(S1):S119-S125.
61.
CordellCBBorsonSBoustaniMet al. Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2013;9(2):141-150.
62.
Hill-BriggsFSmithAS. Evaluation of diabetes and cardiovascular disease print patient education materials for use with low-health literate populations. Diabetes Care. 2008;31(4):667-671.
63.
Hill-BriggsFLazoMRenoskyREwingC. Usability of a diabetes and cardiovascular disease education module in an African American, diabetic sample with physical, visual, and cognitive impairment. Rehabilitation Psychology. 2008;53(1):1-8.
64.
OlfsonMGerhardTHuangCet al. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015:72(12):1172-1181.
65.
De HertMCorrellCUBobesJet al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry2011;10:52-77.
66.
MooreSShiersDDalyBMitchellAJet al. Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care. Acta Psychiatr Scand. 2015;132:109-121.
67.
OsbyUBrandtLCorreiaNet al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatr. 2001;58: 844-850.
68.
CuijpersPVogelzangsNTwiskJ. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014;171:453-462.
69.
WhitleyRCampbellDR.Stigma, agency and recovery amongst people with severe mental illness. 2014Social Science & Medicine, 107
70.
SiltonNRFlannellyKJMilsteinGVaalerML. Stigma in America: has anything changed? Impact of perceptions of mental illness and dangerousness on the desire for social distance: 1996 and 2006. J Nerv Ment Dis2011;199:361-366.
71.
KnaakSMantlerESzetoA. Mental illness-related stigma in healthcare: Barriers to access and care and evidence-based solutions. Health mgt forum, 30(2), 111-116
72.
YanosPTRoeDMarkusKLysakerPH. Pathways between internalized stigma and outcomes related to recovery in schizophrenia spectrum disorders. Psychiatr Serv2008;59:1437-1442
73.
CorriganPWMittalDReavesCMet al. Mental health stigma and primary care decisions. Psychiatry Res2014;218:35-38
74.
GoldbergRWKreyenbuhlJAMedoffDRet al. Quality of diabetes care among adults with serious mental illness. Psychriatr Serv2007;58:536-543
75.
ScottDPalatania-PhungCHappellB. Quality of care for cardiovascular disease and diabetes amongst individuals with serious mental illness and those using antipsychotic medications. J Healthc Qual2012;34:15-21
76.
DixonLBKreyenbuhlJADickersonFBet al. A comparison of type 2 diabetes outcomes among persons with and without severe mental illness. Psychiatr Serv2004;55:892-900
77.
BrownCHMedoffDDickersonFBet al. Long-term glucose control among type 2 diabetes patients with and without severe mental illness. J Nerv Ment Dis2011;199:899-902
78.
HammJABuckKDGonzalvoJD. Clinical application of patient centered approach to diabetes care for people with serious mental illness. Clinical Diabetes2017;35(5):313-320.
79.
LawrenceDKieselySPaisJet al. The epidemiology of excess mortality in people with mental illness. Can J Psychiatry. 2010;55(12):752-760.
80.
Antipsychotics. Lexi-drugs. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed August 29, 2018.
81.
RiordanHJAntoniniPMurphyMF. Atypical antipsy-chotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications. Am Health Drug Benefits. 2011;4(5):292-302.
82.
WhartonSRaiberLSerodioKLeeJChristensenRA. Medications that cause weight gain and alternatives in Canada: a narrative review. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2018;Volume 11:427-438. doi:10.2147/dmso.s171365.
83.
EbbertJOWyattKDHaysJTet al. Varenicline for smoking cessation: efficacy, safety, and treatment recommendations. Patient Prefer Adherence. 2010; 4: 355-362
84.
AnthenelliRobert MBenowitzNeal LWestRobertSt AubinLisaMcRaeThomasLawrenceDavidAscherJohnRussCristinaKrishenAlokEvinsA Eden. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet2016; 387: 2507-20.
85.
AdedinsewoDTakeNAgasthiPet al. Prevalence and Factors Associated With Statin Use Among a Nationally Representative Sample of US Adults: National Health and Nutrition Examination Survey, 2011-2012. Clin Cardiol. 2016Sep;39(9):491-6. doi: 10.1002/clc.22577. Epub 2016 Aug 9.
86.
TrompetSvanVlietPdeCraenAJollesJBuckleyBMurphyM.Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J Neurol2010;257:85-90.
WagstaffLRMittonMWArvikBMDoraiswamyPM.Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy2003;23:871-80.
Van VlietPvan de WaterWde CraenAet al. The influence of age on the association between cholesterol and cognitive function. Exp Gerontol44:112-22.
92.
MuldoonMRyanCSereikaSFloryJManuckS.Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med2004;117:823-29.
93.
CramerCHaanMGaleaSLangaKKalbfleischJ.Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology2008;71:344-50.
94.
ParkerBAPolkDMRabdiyaVet al. Changes in memory function and neuronal activation associated with atorvastatin therapy. Pharmacotherapy2010;30:236e-40e.
95.
ZamriniEMcGwinGRosemanJM.Association between statin use and Alzheimer’s disease. Neuroepidemiology2004;23:94-8.
96.
MuldoonMBargerSRyanCFloryJLehoczkyJMatthewsKet al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med2000;108:538-47.
97.
ZandiPPSparksDLKhachaturianASet al. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry2005;62:217-24.
98.
Benito-LeonJLouisEDVegaSBermejo-ParejaF.Statins and cognitive functioning in the elderly: a population-based study. J Alzheimers Dis2010;21:95-102.
99.
ZhouBTeramukaiSFukushimaM.Prevention and treatment of dementia or Alzheimer’s disease by statins: a meta-analysis. Dement Geriatr Cogn Disord2007;23:194-201.
100.
BeydounMABeason-HeldLLKitner-TrioloMHet al. Statins and serum cholesterol’s associations with incident dementia and mild cognitive impairment. J Epidemiol Community Health2011;65:949-57.
101.
MansiIFreiCRPughMMortensenEM.Psychological Disorders and Statin Use: A Propensity ScoreMatched Analysis. Pharmaco-therapy. 2013June ; 33(6): 615-626.
102.
PowersMARichterSAAckardDMet al. Diabetes distress among persons with type 1 diabetes. Diabetes Educ2017;43(10): 105-113.
103.
SchmittAReimerAHarmannsNet al. Depression is linked to hyperglycaemia via suboptimal diabetes self-management: A cross-sectional mediation analysis. J Psychosom Res2017;94:17-23.
104.
PowersMABardsleyJCypressMet al. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Educ. 2015Aug;41(4):417-30.
WangBAnXShiXet al. Management of endocrine disease: suicide risk in patients with diabetes: a systematic review and meta-analysis. Eur J Endocrinol2017;177(4):R169-181.
107.
LutzJMortonKTurianoNAet al. Health conditions and passive suicidal ideation in the survey of health, ageing, and retirement in Europe. J Gerontoll B Psychol Sci Soc Sci2016; 71(5):936-46.
108.
WangYTangSXuSet al. Association between diabetes and risk of suicide death: a meta-analysis of 3 million participants. Compr Psychiatry2016;71:11-16.
109.
SarkarSBalharaYP.Diabetes mellitus and suicide. Indian J Endocrinol Metab. 2014:18(4):468-74.
110.
ClementSSchaumanOGrahamTet al. What is the impact of metal health-related stigma on help-seeking?: a systematic review of quantitative and qualitative studies. Psychol Med2015;45(1):11-27.
111.
CorriganP.How stigma interferes with mental health care. Am Psychol2004;59(7):614-625.
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Health Disorders, 5th ed.Arlington, VA: American Psychiatric Publishing.
WassermanRMAndersonBJSchwartzDD.Screening of neuro-cognitive and executive functioning in children, adolescents, and young adults with type 1 diabetes. Diabetes Spectrum. 2016; 29(4):202-210.